Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Fast identification of biological pathways associated with a quantitative trait using group lasso with overlaps.

Silver M, Montana G; Alzheimer's Disease Neuroimaging Initiative.

Stat Appl Genet Mol Biol. 2012 Jan 6;11(1):Article 7. doi: 10.2202/1544-6115.1755.

2.

Penalized classification using Fisher's linear discriminant.

Witten DM, Tibshirani R.

J R Stat Soc Series B Stat Methodol. 2011 Nov;73(5):753-772.

3.

Neuroimaging measures as endophenotypes in Alzheimer's disease.

Braskie MN, Ringman JM, Thompson PM.

Int J Alzheimers Dis. 2011 Mar 31;2011:490140. doi: 10.4061/2011/490140.

4.

2011 Alzheimer's disease facts and figures.

Alzheimer's Association.

Alzheimers Dement. 2011 Mar;7(2):208-44. doi: 10.1016/j.jalz.2011.02.004.

PMID:
21414557
5.

Sex differences in grey matter atrophy patterns among AD and aMCI patients: results from ADNI.

Skup M, Zhu H, Wang Y, Giovanello KS, Lin JA, Shen D, Shi F, Gao W, Lin W, Fan Y, Zhang H; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2011 Jun 1;56(3):890-906. doi: 10.1016/j.neuroimage.2011.02.060. Epub 2011 Feb 26.

6.

Resequencing and follow-up of neurexin 1 (NRXN1) in schizophrenia patients.

Mühleisen TW, Basmanav FB, Forstner AJ, Mattheisen M, Priebe L, Herms S, Breuer R, Moebus S, Nenadic I, Sauer H, Mössner R, Maier W, Rujescu D, Ludwig M, Rietschel M, Nöthen MM, Cichon S.

Schizophr Res. 2011 Apr;127(1-3):35-40. doi: 10.1016/j.schres.2011.01.001. Epub 2011 Feb 1.

PMID:
21288692
7.

Whole transcriptome sequencing reveals gene expression and splicing differences in brain regions affected by Alzheimer's disease.

Twine NA, Janitz K, Wilkins MR, Janitz M.

PLoS One. 2011 Jan 21;6(1):e16266. doi: 10.1371/journal.pone.0016266.

8.

Discriminant analysis of longitudinal cortical thickness changes in Alzheimer's disease using dynamic and network features.

Li Y, Wang Y, Wu G, Shi F, Zhou L, Lin W, Shen D; Alzheimer's Disease Neuroimaging Initiative.

Neurobiol Aging. 2012 Feb;33(2):427.e15-30. doi: 10.1016/j.neurobiolaging.2010.11.008. Epub 2011 Jan 26.

9.

The role of neurexins in schizophrenia and autistic spectrum disorder.

Reichelt AC, Rodgers RJ, Clapcote SJ.

Neuropharmacology. 2012 Mar;62(3):1519-26. doi: 10.1016/j.neuropharm.2011.01.024. Epub 2011 Jan 22. Review.

PMID:
21262241
10.

Multimodal classification of Alzheimer's disease and mild cognitive impairment.

Zhang D, Wang Y, Zhou L, Yuan H, Shen D; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2011 Apr 1;55(3):856-67. doi: 10.1016/j.neuroimage.2011.01.008. Epub 2011 Jan 12.

11.

Alzheimer's disease: diagnostics, prognostics and the road to prevention.

Grossman I, Lutz MW, Crenshaw DG, Saunders AM, Burns DK, Roses AD.

EPMA J. 2010 Jun;1(2):293-303. Epub 2010 Jun 29.

12.

Progress and promise of genome-wide association studies for human complex trait genetics.

Stranger BE, Stahl EA, Raj T.

Genetics. 2011 Feb;187(2):367-83. doi: 10.1534/genetics.110.120907. Epub 2010 Nov 29. Review.

13.

The genetics of Alzheimer disease: back to the future.

Bertram L, Lill CM, Tanzi RE.

Neuron. 2010 Oct 21;68(2):270-81. doi: 10.1016/j.neuron.2010.10.013. Review.

14.

Gene expression profiling in the stress control brain region hypothalamic paraventricular nucleus reveals a novel gene network including amyloid beta precursor protein.

Tsolakidou A, Czibere L, Pütz B, Trümbach D, Panhuysen M, Deussing JM, Wurst W, Sillaber I, Landgraf R, Holsboer F, Rein T.

BMC Genomics. 2010 Oct 8;11:546. doi: 10.1186/1471-2164-11-546.

15.

Discovering genetic associations with high-dimensional neuroimaging phenotypes: A sparse reduced-rank regression approach.

Vounou M, Nichols TE, Montana G; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2010 Nov 15;53(3):1147-59. doi: 10.1016/j.neuroimage.2010.07.002. Epub 2010 Jul 17.

16.

Genetic patterns of correlation among subcortical volumes in humans: results from a magnetic resonance imaging twin study.

Eyler LT, Prom-Wormley E, Fennema-Notestine C, Panizzon MS, Neale MC, Jernigan TL, Fischl B, Franz CE, Lyons MJ, Stevens A, Pacheco J, Perry ME, Schmitt JE, Spitzer NC, Seidman LJ, Thermenos HW, Tsuang MT, Dale AM, Kremen WS.

Hum Brain Mapp. 2011 Apr;32(4):641-53. doi: 10.1002/hbm.21054.

17.

Automatic classification of patients with Alzheimer's disease from structural MRI: a comparison of ten methods using the ADNI database.

Cuingnet R, Gerardin E, Tessieras J, Auzias G, Lehéricy S, Habert MO, Chupin M, Benali H, Colliot O; Alzheimer's Disease Neuroimaging Initiative.

Neuroimage. 2011 May 15;56(2):766-81. doi: 10.1016/j.neuroimage.2010.06.013. Epub 2010 Jun 11.

PMID:
20542124
18.

Boosting power for clinical trials using classifiers based on multiple biomarkers.

Kohannim O, Hua X, Hibar DP, Lee S, Chou YY, Toga AW, Jack CR Jr, Weiner MW, Thompson PM; Alzheimer's Disease Neuroimaging Initiative.

Neurobiol Aging. 2010 Aug;31(8):1429-42. doi: 10.1016/j.neurobiolaging.2010.04.022. Epub 2010 Jun 11.

19.

Alzheimer's Disease Neuroimaging Initiative biomarkers as quantitative phenotypes: Genetics core aims, progress, and plans.

Saykin AJ, Shen L, Foroud TM, Potkin SG, Swaminathan S, Kim S, Risacher SL, Nho K, Huentelman MJ, Craig DW, Thompson PM, Stein JL, Moore JH, Farrer LA, Green RC, Bertram L, Jack CR Jr, Weiner MW; Alzheimer's Disease Neuroimaging Initiative.

Alzheimers Dement. 2010 May;6(3):265-73. doi: 10.1016/j.jalz.2010.03.013.

20.

Implication of the immune system in Alzheimer's disease: evidence from genome-wide pathway analysis.

Lambert JC, Grenier-Boley B, Chouraki V, Heath S, Zelenika D, Fievet N, Hannequin D, Pasquier F, Hanon O, Brice A, Epelbaum J, Berr C, Dartigues JF, Tzourio C, Campion D, Lathrop M, Amouyel P.

J Alzheimers Dis. 2010;20(4):1107-18. doi: 10.3233/JAD-2010-100018.

PMID:
20413860

Supplemental Content

Support Center